SN
Srivastava Neera
About Srivastava Neera
Data last updated:
Srivastava Neera is a Director at Aventus Pharmaceutical Private Limited (since 2022), Director at Jivdhara Pharma Private Limited (since 2021) and Director at Indigenius R & D Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.02 Cr; the largest is Aventus Pharmaceutical Private Limited at ₹85.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aventus Pharmaceutical Private Limited U24290MP2022PTC059864 | Director | 08 Mar 2022 | 2022 | ₹85.4 Lakh (FY 2025) | Active |
| Jivdhara Pharma Private Limited U24230MP2021PTC056656 | Director | 12 Jul 2021 | 2021 | ₹17.1 Lakh (FY 2025) | Active |
| Indigenius R & D Private Limited U46497MP2024PTC069268 | Director | 08 Jan 2024 | 2024 | Active | |
| Shimira Pharma Private Limited U24239MP2021PTC056775 | Director | 21 Jul 2021 | 2021 | Active |
Board colleagues of Srivastava Neera
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pravesh Jain | 05134355 | Aventus Pharmaceutical Private Limited | Director |
| Pramod Srivastava | 09236906 | Jivdhara Pharma Private Limited , Shimira Pharma Private Limited | Director |
| Salil Shrivastava | 00223684 | Jivdhara Pharma Private Limited | Director |
| Sameer Shrivastava | 05195141 | Jivdhara Pharma Private Limited | Director |
| Sourabh Yadav | 08862297 | Indigenius R & D Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srivastava Neera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srivastava Neera
Srivastava Neera currently holds 4 directorships: Aventus Pharmaceutical Private Limited (Director, since 08 Mar 2022, revenue ₹85.4 Lakh (FY 2025)); Jivdhara Pharma Private Limited (Director, since 12 Jul 2021, revenue ₹17.1 Lakh (FY 2025)); Indigenius R & D Private Limited (Director, since 08 Jan 2024); Shimira Pharma Private Limited (Director, since 21 Jul 2021).
Srivastava Neera was first appointed on 12 Jul 2021 as Director at Jivdhara Pharma Private Limited. The most recent appointment on record is 08 Jan 2024 at Indigenius R & D Private Limited.
The 2 current companies of Srivastava Neera that report revenue have a combined latest revenue of ₹1.02 Cr: Aventus Pharmaceutical Private Limited ₹85.4 Lakh (FY 2025); Jivdhara Pharma Private Limited ₹17.1 Lakh (FY 2025).
The current boards of Srivastava Neera's companies include Pravesh Jain (Aventus Pharmaceutical Private Limited), Pramod Srivastava (Jivdhara Pharma Private Limited), Salil Shrivastava (Jivdhara Pharma Private Limited), Sameer Shrivastava (Jivdhara Pharma Private Limited), Sourabh Yadav (Indigenius R & D Private Limited).